A Prospective Registry Study of Laparoscopic-endoscopic Cooperative Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer
| Registry | NCT07615374 |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; na, single group, masking: none, treatment |
| Enrollment | 36 (Estimated) |
| Sponsor | Jilin University (Other) |
| Conditions | Early Gastric Cancer |
| Interventions | Laparoscopic-endoscopic cooperative surgery (LECS) Assisted Sentinel Lymph Node Navigation Surgery (Procedure) |
| Dates | start 2026-05-12, primary completion 2028-12-31 (estimated), completion 2029-12-31 (estimated), first posted 2026-05-29, last updated 2026-09-14 |
| Locations | 2 sites in China |
Related Papers Related Patents Related Grants Related Experts
All trials for Early Gastric Cancer All trials of Laparoscopic-endoscopic cooperative surgery (LECS) Assisted Sentinel Lymph Node Navigation Surgery
This study is to evaluate the safety and efficacy of dual-endoscope assisted sentinel lymph node navigation surgery for early gastric cancer (EGC).
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Sentinel Lymph Node Navigation Surgery | Experimental | Procedure: Laparoscopic-endoscopic cooperative surgery (LECS) Assisted Sentinel Lymph Node Navigation Surgery | Laparoscopic-endoscopic cooperative surgery (LECS) Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer |
Sex: All
Inclusion Criteria: * Preoperative assessment indicating that the tumor was confined to the mucosa or submucosa, consistent with the diagnosis of early gastric cancer. * Patients who required additional surgical intervention following initial endoscopic submucosal dissection (ESD) based on postoperative pathological evaluation. * Patients and their families fully understood the procedure, requested dual-endoscope assisted sentinel lymph node navigation surgery, agreed to participate in this clinical study, and signed the informed consent form. Exclusion Criteria: * Preoperative assessment indicating suspected lymph node or distant metastasis. * History of complex abdominal surgery rendering laparoscopic treatment infeasible. * Participation in another clinical trial within 4 weeks prior to enrollment or currently participating in another trial. * History of severe psychiatric disorders. * Pregnant or lactating women. * Uncontrolled infection prior to surgery. * Presence of other malignancies or comorbidities that may significantly affect survival. * Any other conditions deemed by the investigators as unsuitable for participation, or refusal by the patient or family to enroll. * Cardiopulmonary, hepatic, and renal functions were unsufficient to tolerate the surgery.
| Facility | City | Country | Status |
|---|---|---|---|
| the First Hospital of Jilin University | Changchun, Jilin | China | Recruiting |
| the First Hospital of Jilin University | Ch’ang-ch’un, Jilin | China | Active not recruiting |